Screening for Chlamydia in Adolescents and Young Women

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Screening for Chlamydia in Adolescents and Young Women

Arcives of Pediatrics & Adolescent Medicine Online (archpedi.ama-assn.org) (11/00) Vol. 154, No. 11,
Mangione-Smith, Rita; McGlynn, Elizabeth A.; Hiatt, Lisa

A study of more than 19,000 sexually active females between the ages of 15 and 25 indicates that rates of chlamydia screening for women in this group could be higher. The subjects were enrolled for calendar year 1997 in one of four major U.S. health plans and had visited their health care provider during that time. While the proportion of females in this age group who were identified as sexually active was similar in the four health plans, there was a great deal of variation for chlamydia screening for eligible females among the plans. There were significant differences between the plans for the types of visits (such as sexually transmitted disease testing or pregnancy) that determined eligibility for chlamydia testing, the researchers found.
001211
AD002194

Copyright © 2000 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.